By Sheri Kasprzak
New York, Feb. 20 - Shire plc settled a £461 million private placement of stock to partially finance its proposed acquisition of New River Pharmaceuticals Inc.
The company sold 42,883,721 shares at £10.75 each.
The New River acquisition is being conducted through a tender offer and merger agreement. The tender offer has not yet commenced.
Shire, based in Basingstoke, England, is a specialty pharmaceutical company focused on treatments for attention deficit hyperactivity disorder, human genetic therapies and gastrointestinal and renal diseases.
| Issuer: | Shire plc
|
| Issue: | Stock
|
| Amount: | £461 million
|
| Shares: | 42,883,721
|
| Price: | £10.75
|
| Warrants: | No
|
| Settlement date: | Feb. 20
|
| Stock symbol: | London: SHP
|
| Stock price: | £11.15 at close Feb. 20
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
